Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_assertion type Assertion NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_head.
- NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_assertion description "[Furthermore, our findings support further analysis of the functional properties of the selected genes, especially SOX4 and BCAT1 for medulloblastoma and SOX9 for ependymoma, to evaluate the use of these genes as potential tumor markers, prognostic markers, and drug targets in pediatric brain tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_provenance.
- NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_assertion evidence source_evidence_literature NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_provenance.
- NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_assertion SIO_000772 18577562 NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_provenance.
- NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_assertion wasDerivedFrom befree-20150227 NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_provenance.
- NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_assertion wasGeneratedBy ECO_0000203 NP259797.RAyDVL662_ZuTCpKWSjwLENy4sv-mMrCPPQo78MrffBhE130_provenance.